BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 16, Issue 9
  • This Article
Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews
©The Author(s) 2025.
World J Clin Oncol. Sep 24, 2025; 16(9): 108585
Published online Sep 24, 2025. doi: 10.5306/wjco.v16.i9.108585
Table 2 Surface antigens targeted in immuno-positron emission tomography for hematologic malignancies
Types of hematologic malignancy
Surface antigens targeted in immuno-PET detection
Non-Hodgkin lymphomaCD19, CD20, CXCR4
Hodgkin lymphomaCD30
Multiple myelomaCD38, CD138, VLA-4, BCMA, SLAMF7, CXCR4
Acute myeloid leukemiaCD33, CXCR4
Acute lymphoblastic leukemiaCXCR4
CXCR4: C-X-C motif chemokine receptor 4; VLA-4: Very late antigen-4; BCMA: B-cell maturation antigen; SLAMF7: Signaling lymphocyte activation molecule F7; Immuno-PET: Immuno-positron emission tomography.
Full Size Table
Write to the Help Desk
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.